Cite
HARVARD Citation
Canonica, G. et al. (2022). Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis. Allergy. 77 (1), pp. 150-161. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Canonica, G. et al. (2022). Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis. Allergy. 77 (1), pp. 150-161. [Online].